IQVIA Holdings Inc. (IQV)
NYSE: IQV · Services-Commercial Physical & Biological Research · Durham, NC · filing with the SEC since 2009
Grade6.8
◀ Past 7.5● Present 7.1▶ Future 5.2
Who owns IQVIA Holdings Inc.
As filed with the SECHolders of 5% or more
2
Vanguard Capital Management holds 7.49% of Common Stock, as its SCHEDULE 13G filed Apr 30, 2026 says.
Directors and officers
18
report now, of 41 people on the record since 2013. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
Harris Associates L P
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.01
GIC Private Ltd
SCHEDULE 13G/A · filed May 9, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What IQV reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Helparound
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Longwood Fund V, L.P.
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Nostra Data Pty Ltd
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Nova Quest Pharma Opportunities Fund Five Lp
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Nova Quest Pharma Opportunities Fund Four Lp
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Nova Quest Private Equity Fund One Lp
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
Pappas Life Science Ventures V L P
An investee · investee · invested in, named in the 10-K filed Feb 17, 2026
432 subsidiaries in 87 countries, from the list filed with the 10-K filed Feb 17, 2026.
Insider tradesForm 4
11sales
0purchases
0sales on a scheduled plan
6people selling
$39.3Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window6 of 46 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Bousbib Ari | Chairman, Chief Executive Officer & President Power of Attorney | 5 | $34.2M | 0 | 0 | $0 |
| Sherbet Eric | See Remarks | 2 | $2.5M | 0 | 0 | $0 |
| Staub W Richard | President, Research & Development Solutions Power of Attorney | 1 | $1.3M | 0 | 0 | $0 |
| Berkshire James G. | EVP, Global Infrastructure and Operations. Power of Attorney | 1 | $700,000 | 0 | 0 | $0 |
| Patel Bhavik | President, MedTech and Consumer Health Power of Attorney | 1 | $400,000 | 0 | 0 | $0 |
| Cherofsky Keriann | SVP, Corporate Controller Power of Attorney | 1 | $100,000 | 0 | 0 | $0 |